Self-Sustained Resistance to Suppression of CD8+ Teff Cells at the Site of Autoimmune Inflammation Can Be Reversed by Tumor Necrosis Factor and Interferon-γ Blockade

Arthritis and Rheumatology

Volumn 68, Issue 1, 2016, Pages 229-236

  Petrelli, Alessandra ^a,b   Wehrens, Ellen J ^a   Scholman, Rianne C ^a   Prakken, Berent J ^a   Vastert, Sebastian J ^a   Van Wijk, Femke ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; CYTOKINE; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOLESCENT; ANTIGEN PRESENTING CELL; ARTICLE; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATION; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL POPULATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYNOVIAL FLUID; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CHILD; CYTOLOGY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; MALE;

ADOLESCENT; ANTIGEN-PRESENTING CELLS; ARTHRITIS, JUVENILE; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHILD; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-6; MALE; SYNOVIAL FLUID; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84952048498     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39418     Document Type: Article

References (17)

1. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G., Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 2012; 39: 222-8.
2. Wehrens EJ, Prakken BJ, van Wijk F., T cells out of control: impaired immune regulation in the inflamed joint. Nat Rev Rheumatol 2013; 9: 34-42.
3. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW., Autoreactive T cells in healthy individuals. J Immunol 2004; 172: 5967-72.
4. Kronenberg M, Rudensky A., Regulation of immunity by self-reactive T cells. Nature 2005; 435: 598-604.
5. Bettini M, Vignali DA., Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009; 21: 612-8.
6. Wehrens EJ, Mijnheer G, Duurland CL, Klein M, Meerding J, van Loosdregt J, et al., Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells. Blood 2011; 118: 3538-48.
7. Wehrens EJ, Vastert SJ, Mijnheer G, Meerding J, Klein M, Wulffraat NM, et al., Anti-tumor necrosis factor α targets protein kinase B/c-Akt-induced resistance of effector cells to suppression in juvenile idiopathic arthritis. Arthritis Rheum 2013; 65: 3279-84.
8. Haufe S, Haug M, Schepp C, Kuemmerle-Deschner J, Hansmann S, Rieber N, et al., Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63: 3153-62.
9. Herrath J, Muller M, Amoudruz P, Janson P, Michaelsson J, Larsson PT, et al., The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur J Immunol 2011; 41: 2279-90.
10. Cho BA, Sim JH, Park JA, Kim HW, Yoo WH, Lee SH, et al., Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis. J Clin Immunol 2012; 32: 709-20.
11. Carvalheiro H, Duarte C, Silva-Cardoso S, da Silva JA, Souto-Carneiro MM., CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity. Arthritis Rheumatol 2015; 67: 363-71.
12. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al., Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
13. Van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS., CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50: 2775-85.
14. Wahl SM, Chen W., Transforming growth factor-β-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 2005; 7: 62-8.
15. Roncarolo MG, Battaglia M., Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007; 7: 585-98.
16. REG-cell therapies for autoimmune rheumatic diseases. Nat Rev Rheumatol 2014; 10: 543-51.
17. Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, et al., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med 2013; 19: 322-8.